New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Alcon

ALC

Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+4.71%
EPS
+12.5%
Free cash flow
+13.3%
Total debt
+0.72%

Quarter to September 2026, against a year earlier

74.31 0.19 −0.26%

After hours trading: 74.32, up 0.01%, last trade 4:08pm Eastern.

Market cap
$35.7B
P/E
54.3×
Fwd P/E FY26e
45.6×
Dividend yield
0.47%
F-score
6/9
ROIC
2.52%
Net debt / EBITDA
1.2×
Payout ratio
0.3×

Revenue to profit Fiscal 2025, year to Dec 31, 2025

Of every $100 of revenue, $9.42 was left as profit. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue10.4100.0%
Cost of revenue−4.7−44.8%
Gross profit5.755.2%
Research & development−1.0−9.5%
Selling, general & admin−3.4−33.2%
Other operating costs+0.10.5%
Operating income1.413.1%
Other income, net−0.2−1.9%
Income tax−0.2−1.7%
Net income1.09.4%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, eight years
FY18FY19FY20FY21FY22FY23FY24FY25
Revenue$7.2B$7.5B$6.8B$8.3B$8.7B$9.5B$9.9B$10.4B
Operating income−$248M−$187M−$482M$580M$672M$1.0B$1.4B$1.4B
Net income−$227M−$656M−$531M$376M$335M$974M$1.0B$980M
Net margin (right axis)−3.2%−8.7%−7.8%4.5%3.8%10.3%10.3%9.4%
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
10,401.00 9,911.00 9,455.00 8,717.00 8,291.00 6,833.00 7,508.00 7,153.00 6,821.43 6,370.59
Revenue Growth
4.94% 4.82% 8.47% 5.14% 21.34% (8.99%) 4.96% 4.86% 7.08% (6.61%)
Gross Profit
5,745.00 5,512.00 5,247.00 4,748.00 4,652.00 2,940.00 3,662.00 3,192.00 3,218.37 3,004.90
Operating Income
1,360.00 1,413.00 1,039.00 672.00 580.00 (482.00) (187.00) (248.00) — —
EBT
1,160.00 1,256.00 832.00 463.00 418.00 (635.00) (332.00) (300.00) (127.55) (108.82)
Income after Tax
980.00 1,018.00 974.00 335.00 376.00 (531.00) (656.00) (227.00) — —
Net Income Common
980.00 1,018.00 974.00 335.00 376.00 (531.00) (656.00) (227.00) 257.14 (163.73)
EPS (Diluted)
1.98 2.05 1.96 0.68 0.76 (1.09) (1.34) (0.46) 0.53 (0.33)
Shares (Diluted, Weighted)
496.20 497.50 496.50 494.40 493.40 489.00 488.20 488.20 489.00 0.00
Gross Margin
55.24% 55.61% 55.49% 54.47% 56.11% 43.03% 48.77% 44.62% 47.18% 47.17%
EBIT Margin
13.08% 14.26% 10.99% 7.71% 7.00% (7.05%) (2.49%) (3.47%) (2.27%) 0.31%
Net Profit Margin
9.42% 10.27% 10.30% 3.84% 4.54% (7.77%) (8.74%) (3.17%) 3.77% (2.57%)
Free Cash Flow Margin
15.51% 14.20% 5.68% 5.41% 1.99% 3.83% 3.25% 5.98% 17.94% 18.88%
EBITDA
2,551.00 2,639.00 2,265.00 1,783.00 1,800.00 1,144.00 1,269.00 1,374.00 1,233.67 1,254.90
EBIT
1,360.00 1,413.00 1,039.00 672.00 580.00 (482.00) (187.00) (248.00) (155.10) 19.61

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 19, 2026